Study to Evaluate Safety, Efficacy and Immunogenicity of Acne mRNA Vaccine in Participants With Mild Acne

Abroad (travel likely)RecruitingPHASE1, PHASE2

Conditions

Acne

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Encino Research Center- Site Number : 8400008, Encino, California, United States
Moore Clinical Research - Brandon- Site Number : 8400007, Brandon, Florida, United States
Encore Research Group-Jacksonville Center for Clinical Research- Site Number : 8400006, Jacksonville, Florida, United States
DelRicht Research- Site Number : 8400003, New Orleans, Louisiana, United States

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Phase 1 Study to Evaluate the Safety, Tolerability, PK, and PD of TVB-3567 in Healthy Participants With or Without Acne

Acne

Abroad (travel likely)RecruitingPHASE1

Tempe, United States · Melbourne, Australia

Creation of a Monocentric Cohort of Patients Treated for Acne at the Nantes University Hospital

Acne

Abroad (travel likely)Recruiting

Nantes, France

Evaluation of Juläine (TM) for the Treatment of Atrophic Facial Acne Scars

Acne Scars

Abroad (travel likely)Recruiting

Gdansk, Poland · Gdynia, Poland

Topical Application of Engineered Lactobacillus Reuteri With a Zinc Sulfate-Tannic Acid MPN Coating for Acne

Acne

Abroad (travel likely)RecruitingPHASE2

Shenzhen, China